Good News to Cancer Patients — Metabolic Research and Cornerstone Pharmaceuticals Conduct a New Animal Study
Metabolic Research, Inc. announced today that an animal study conducted in cooperation with Cornerstone Pharmaceuticals, Inc. of Cranbury, NJ, confirmed that “ABL-SA” protein found in a Brazilian mushroom (a key component in Metabolic Research’s Polimmune ™ supplement) is effective in avidly binding to particularly aggressive lung cancer cells called H460, in mice.
This entry was posted on Monday, August 27th, 2007 at 3:20 pm and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.